Pre-emptive Anakinra for Cytokine Event Reduction
Conditions
- B-Acute Lymphoblastic Leukemia
- CAR-T Cell Therapy
- Cytokine Release Syndrome
- Immune Effector Cell Associated Neurotoxicity Syndrome
- Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome
Interventions
- DRUG: Anakinra (Kineret®)
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborators